The Complete Facial Aesthetic Solution
Discover the eLight™ Advantage
Powered by the revolutionary el?s™ Technology, eLight is the complete facial aesthetic solution for the successful treatment of all skin textures and all skin tones. eLight empowers you to meet patient demand for non-invasive, facial aesthetic improvements with zero downtime.
- The only non-invasive treatment with FDA-approval for Skin Tightening via Wrinkle Treatment
- Superior performance and patient comfort
- Virtually painless skin tightening — without surgery
- Firm and tighten lax skin
- Visit Consumer Website: Refirme.com - created to increase patient traffic into our clients' practice
- The first and only radio frequency based FotoFacialRF™
- Treat superficial benign vascular and pigmented lesions, including telangiectasias, symptoms of rosacea and angioma
- Resolves stubborn and resistant superficial benign pigmented and vascular lesions on lighter skin colors
- Offer your patients the most in-demand aesthetic procedure today
- Treat even minimally-pigmented hair colors and all skin colors
- Clinically proven, safe, effective acne treatment
- Reduce sebaceous gland activity and destroy active acne
- Significantly less energy required than conventional lasers and IPLs
Cost of shipping and handling within the continental United States is $1,000.00. All other buyers please contact us for shipping information.
“Please Note:"
"The sale of this item may be subject to regulation by the U.S. Food and Drug Administration and state and local regulatory agencies. If so, do not bid on this item unless you are an authorized purchaser. If the item is subject to FDA regulation, I will verify your status as an authorized purchaser of this item before shipping of the item."
If you have questions about legal obligations regarding sales of medical devices, you should consult with the FDA's Center for Devices and Radiological Health:
Links:http://www.fda.gov/cdrh/devadvice/ or http://www.fda.gov/cdrh/ind
ustry/support/index.html
Phone number: 800.638.2041
email: dsmica@cdrh.fda.gov
|